1. Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study. (May 2022) Authors: Diamantopoulos, Panagiotis T.; Stafylidis, Christos; Vlachopoulou, Dimitra; Kontandreopoulou, Christina-Nefeli; Giannakopoulou, Nefeli; Vardaka, Maria; Mpouhla, Anthi; Mastrogianni, Elpida; Variami, Eleni; Galanopoulos, Athanasios; Pappa, Vasiliki; Psichogiou, Mina; Hatzakis, Angelos; Viniou, Nor... Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗